Eva Aström

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. pmc Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta
    Eva Aström
    Department of Woman and Child Health, Astrid Lindgren Children s Hospital, Karolinska Institute, Stockholm, Sweden
    Arch Dis Child 92:332-8. 2007
  2. doi Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta
    E Aström
    Department of Women s and Children s Health, Karolinska Institutet, Stockholm, Sweden
    Acta Paediatr 99:1834-40. 2010
  3. doi Intravenous pamidronate treatment improves growth in prepubertal osteogenesis imperfecta patients
    Terhi J Heino
    Pediatric Endocrinology, Department of Women s and Children s Health, Astrid Lindgren Children s Hospital, Karolinska Institutet, Stockholm, Sweden
    Horm Res Paediatr 75:354-61. 2011
  4. doi No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates
    Barbro Malmgren
    Department of Paediatrics, Karolinska University Hospital Huddinge, Stockholm, Sweden
    J Oral Pathol Med 37:196-200. 2008
  5. ncbi Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta
    Kristina Löwing
    Department of Woman and Child Health, Astrid Lindgren Children s Hospital, Karolinska Institutet, Sweden
    Acta Paediatr 96:1180-3. 2007
  6. ncbi Etomidate-Lipuro is associated with considerably less injection pain in children compared with propofol with added lidocaine
    Y Nyman
    Department of Paediatric Anaesthesia and Intensive Care, Astrid Lindgrens Children s Hospital, Karolinska Hospital, Stockholm, Sweden
    Br J Anaesth 97:536-9. 2006
  7. doi Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children
    S Lundeberg
    Department of Pediatric Anesthesia and Intensive Care, Astrid Lindgren Children s Hospital, Karolinska University Hospital, Stockholm, Sweden
    Acta Anaesthesiol Scand 54:435-41. 2010
  8. ncbi Clonidine in paediatric anaesthesia: review of the literature and comparison with benzodiazepines for premedication
    H Bergendahl
    Department of Anaesthesia, Intensive, and Pain Care, Karolinska University Hospital, Huddinge, Sweden
    Acta Anaesthesiol Scand 50:135-43. 2006
  9. ncbi Clonidine vs. midazolam as premedication in children undergoing adeno-tonsillectomy: a prospective, randomized, controlled clinical trial
    H T G Bergendahl
    Department of Paediatric Anaesthesia and Intensive Care, Astrid Lindgrens Children s Hospital, Stockholm, Sweden
    Acta Anaesthesiol Scand 48:1292-300. 2004
  10. ncbi Propofol injection pain in children: a prospective randomized double-blind trial of a new propofol formulation versus propofol with added lidocaine
    Y Nyman
    Department of Paediatric Anaesthesia and Intensive Care, Astrid Lindgrens Children s Hospital, Karolinska Institutet, Stockholm, Sweden
    Br J Anaesth 95:222-5. 2005

Collaborators

Detail Information

Publications19

  1. pmc Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta
    Eva Aström
    Department of Woman and Child Health, Astrid Lindgren Children s Hospital, Karolinska Institute, Stockholm, Sweden
    Arch Dis Child 92:332-8. 2007
    ..Children with the severe forms of osteogenesis imperfecta have in several studies been treated with intravenous pamidronate, but there are only few reports of the effect of early treatment...
  2. doi Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta
    E Aström
    Department of Women s and Children s Health, Karolinska Institutet, Stockholm, Sweden
    Acta Paediatr 99:1834-40. 2010
    ....
  3. doi Intravenous pamidronate treatment improves growth in prepubertal osteogenesis imperfecta patients
    Terhi J Heino
    Pediatric Endocrinology, Department of Women s and Children s Health, Astrid Lindgren Children s Hospital, Karolinska Institutet, Stockholm, Sweden
    Horm Res Paediatr 75:354-61. 2011
    ..Pamidronate is widely used to treat pediatric patients with osteogenesis imperfecta (OI). We aimed at delineating the effects of monthly pamidronate therapy on the growth of different body segments in prepubertal OI patients...
  4. doi No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates
    Barbro Malmgren
    Department of Paediatrics, Karolinska University Hospital Huddinge, Stockholm, Sweden
    J Oral Pathol Med 37:196-200. 2008
    ....
  5. ncbi Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta
    Kristina Löwing
    Department of Woman and Child Health, Astrid Lindgren Children s Hospital, Karolinska Institutet, Sweden
    Acta Paediatr 96:1180-3. 2007
    ..To evaluate the effect of intravenous pamidronate therapy on everyday activities, well-being, skeletal pain and bone density in children with osteogenesis imperfecta (OI)...
  6. ncbi Etomidate-Lipuro is associated with considerably less injection pain in children compared with propofol with added lidocaine
    Y Nyman
    Department of Paediatric Anaesthesia and Intensive Care, Astrid Lindgrens Children s Hospital, Karolinska Hospital, Stockholm, Sweden
    Br J Anaesth 97:536-9. 2006
    ..v. induction of anaesthesia between propofol with added lidocaine (previous standard) and this new etomidate formulation in paediatric patients...
  7. doi Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children
    S Lundeberg
    Department of Pediatric Anesthesia and Intensive Care, Astrid Lindgren Children s Hospital, Karolinska University Hospital, Stockholm, Sweden
    Acta Anaesthesiol Scand 54:435-41. 2010
    ..The aim of this clinical trial was to explore the pharmacokinetics of ketobemidone in children because these properties have not been reported previously...
  8. ncbi Clonidine in paediatric anaesthesia: review of the literature and comparison with benzodiazepines for premedication
    H Bergendahl
    Department of Anaesthesia, Intensive, and Pain Care, Karolinska University Hospital, Huddinge, Sweden
    Acta Anaesthesiol Scand 50:135-43. 2006
    ..Clonidine has contrary to midazolam no effect on respiration. We believe that clonidine is a good alternative to midazolam as premedication in infants and children...
  9. ncbi Clonidine vs. midazolam as premedication in children undergoing adeno-tonsillectomy: a prospective, randomized, controlled clinical trial
    H T G Bergendahl
    Department of Paediatric Anaesthesia and Intensive Care, Astrid Lindgrens Children s Hospital, Stockholm, Sweden
    Acta Anaesthesiol Scand 48:1292-300. 2004
    ..The aim of the current study was to compare postoperative outcome variables using a prospective, randomized, double-blind design after premedication with clonidine or midazolam...
  10. ncbi Propofol injection pain in children: a prospective randomized double-blind trial of a new propofol formulation versus propofol with added lidocaine
    Y Nyman
    Department of Paediatric Anaesthesia and Intensive Care, Astrid Lindgrens Children s Hospital, Karolinska Institutet, Stockholm, Sweden
    Br J Anaesth 95:222-5. 2005
    ....
  11. doi Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy
    Kristina Tedroff
    Neuropediatric Unit, Department of Women s and Children s Health, Karolinska Institutet, Astrid Lindgren Children s Hospital, Stockholm, Sweden
    Dev Med Child Neurol 53:724-9. 2011
    ..The aim of this study was to evaluate the long-term effects of selective dorsal rhizotomy (SDR) in children with cerebral palsy (CP)...
  12. ncbi Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig
    A Ekborn
    Department of Physiology, Karolinska Institute and ENT Clinic Karolinska Hospital, SE 17176, Stockholm, Sweden
    Hear Res 140:38-44. 2000
    ..The interindividual variability in susceptibility to ABR threshold shift was far greater than the variability in pharmacokinetics, suggesting that other factors are more important in determining the degree of hearing loss...
  13. ncbi Plasma pharmacokinetics of etoposide (VP-16) after i.v. administration to children
    S Eksborg
    Karolinska Pharmacy, Karolinska Hospital and Institute, Stockholm, Sweden
    Anticancer Drugs 11:237-41. 2000
    ..The two DS patients did not experience any enhanced degree of toxicity from their etoposide treatments. The results support that dosing of etoposide to children should be based on body surface area...
  14. ncbi Blood-borne factors possibly associated with post-operative nausea and vomiting: an explorative study in women after breast cancer surgery
    E Oddby-Muhrbeck
    Division of Anaesthesia and Intensive Care, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
    Acta Anaesthesiol Scand 49:1346-54. 2005
    ..The aim of the present explorative study was to identify blood-borne factors that might be associated with the development of PONV in women undergoing breast cancer surgery as a basis for further studies...
  15. ncbi A comparative pharmacokinetic study of doxorubicin and 4'-epi-doxorubicin in children with acute lymphocytic leukemia using a limited sampling procedure
    S Eksborg
    Karolinska Pharmacy, Karolinska Hospital, Stockholm, Sweden
    Anticancer Drugs 11:129-36. 2000
    ..The Cmax ratio Dox/Epi was 1.39+/-0.19 (mean +/- SD). The pharmacokinetic differences of Dox and Epi in children, although less pronounced than in adults, are still of a magnitude that might be of clinical importance...
  16. ncbi In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells
    Y Wang
    Department of Oncology Pathology, Cancer Center Karolinska, Karolinska Institute and Hospital, Stockholm, Sweden
    Anticancer Drugs 10:921-8. 1999
    ..Regardless of the P-gp levels of the treated cells, DaunoXome showed the same cytotoxic effect despite lower intracellular accumulation (range 22-47%), compared with conventional daunorubicin...
  17. ncbi Evaluation of clinical assays for measuring high-dose methotrexate in plasma
    F Albertioni
    Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden
    Clin Chem 42:39-44. 1996
    ..The interference from 7-OHMTX was, however, somewhat less pronounced for FPIA2 (monoclonal) than for FPIA1 (polyclonal)...
  18. ncbi Pharmacokinetics of anthracyclines
    S Eksborg
    Karolinska Pharmacy, Stockholm, Sweden
    Acta Oncol 28:873-6. 1989
    ..The observed increase of the mean residence time (MRT) supports the assumption of an increased drug exposure of the tumour caused by Spherex...
  19. ncbi Plasma pharmacokinetics of Idarubicin and its 13-hydroxymetabolite after intravenous and oral administration under fasting and non-fasting conditions
    S Eksborg
    Karolinska Pharmacy, Stockholm, Sweden
    Acta Oncol 29:921-5. 1990
    ..v. and oral therapy with Idarubicin. The pharmacokinetics of Idarubicinol was not affected by food intake...